Sandboxing, demonstrated value, and a hard line at clinical judgment: a physician-researcher’s three-question test before AI touches a trial.
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Building Effective, Retrospective Decision-Grade Disease Registries
- To Pick The Right Medical LLM, First Assess Your Readiness
- Clinical Trial Tech Fails On Systems, Not Software
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Overcoming Oncology Trial Challenges With ePRO Solutions
Discover effective strategies and solutions to overcome challenges in oncology studies and how to optimize trial design, patient recruitment, data management, and regulatory compliance.
-
Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits
Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.
-
How eCOA Improves Patient Experience
Explore how to ensure that clinical trials are truly patient-centered, and why it is critical to do so.
-
IRT? RTSM? What's The Difference?
What are the components of Randomization and Trial Supply Management (RTSM) and the critical role of RTSM and Interactive Response Technology (IRT) in clinical trials?
-
The Impact Of Clinical Trial Payments On Site-Sponsor Relationships
The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.
-
Configuration Over Code: Why RTSM Architecture Matters Long After Go-Live
Learn how configuration-driven RTSM architecture can simplify protocol changes, reduce operational burden, and help teams manage amendments with greater efficiency and control.
-
The Science Behind Medable's Health Economics And Outcomes Research
Meet the team responsible for ensuring the scientific rigor and outcomes of Medable’s clinical trial platform, and uncover how they’ve been pioneering eCOA and ePRO research for decades.
-
On-Site ePRO In Action
Bridge the gap between clinic and home with flexible data capture. Use any device to ensure consistent, real-time data entry and improve compliance throughout the study lifecycle.
-
To Counter Bias, Counterbalance
It’s easy to overlook the effects a survey’s format can have on responses, but those effects are potent sources of bias. Modern EDC allows you to systematically vary both question and response option order. This practice, called counterbalancing, guards against unwanted order effects.
-
Why eSource: The Advantages of Abandoning Paper Records
Eliminate transcription errors and fully leverage supporting eClinical technology to provide a reliable consistent exchange of information.
- A Framework For Deploying AI In Clinical Trials Without The Hype
- Why Younger Clinical Researchers Are More Wary Of AI Than Their Elders
- Inside The Rush To Accelerated Approval: A Consultant's View
- Why Virtua Health's AI Committee Gives IT The Review, Not The Vote
- Clinical Trial Tech Fails On Systems, Not Software
RECENT NEWSLETTERS
- 10.15.26 -- AI, Site Burden, And Vendor Risks Are Testing Trials
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps